|Videos|June 13, 2023
Behind the Science: Behind Key Data From ASCO 2023
Experts discuss the key findings presented at ASCO 2023, including the TRIMM-2 trial in multiple myeloma, the NATALEE trial in HR+/HER2- early breast cancer, and more.
Experts discuss the key findings presented at ASCO 2023, including the TRIMM-2 trial in multiple myeloma, the NATALEE trial in HR+/HER2- early breast cancer, and more.